Crewe Advisors LLC Jazz Pharmaceuticals PLC Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$114.26 - $136.0 $2,285 - $2,720	20 New	20 $2,000
Q2 2023 Jul 28, 2023	SELL	$122.5 - $147.16 $5,390 - $6,475	-44 Reduced 68.75%	20 $2,000
Q2 2022 Aug 02, 2022	BUY	$141.59 - $168.66 $9,061 - $10,794	64 New	64 $10,000
Q1 2022 Apr 27, 2022	SELL	$129.64 - $160.7 $7,778 - $9,642	-60 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$119.87 - $145.67 $7,192 - $8,740	60 New	60 $8,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.